Navigation Links
PointCross Life Sciences Opens New Office in Silver Spring, Maryland for Data Standardization of Nonclinical Studies

FOSTER CITY, Calif., July 9, 2013 /PRNewswire/ -- Extending its recently announced Data Standardization Service, PointCross Life Sciences announced that it has opened a new center in Silver Spring, MD, USA where studies submitted by sponsors to the FDA in PDF and other formats will be standardized to fit into the Agency's NIMS (Nonclinical Information Management System) environment.  Increased access to such structured study data combined with computational review tools in NIMS are aligned with the Agency's goals of integrating regulatory history into scientific information and advancing regulatory science research.


The PointCross team in the Maryland center applies the same methodology, processes, computational tools and information security controls used by other centers at PointCross Life Sciences.  It will focus on standardization of studies already submitted to the FDA. 

New studies that require extensions to the NIMS data model to handle novel protocols, innovative studies and new study types will be modeled and provided to the FDA.

About PointCross Life Sciences, Inc.

PointCross Life Sciences, Inc. is a global provider of Big Data analytics, data store and translational informatics solutions and Data Standardization Services designed for large, complex, and weakly structured datasets.  Our offerings are used by researchers and reviewers involved with drug development, and are available behind the Enterprise firewall or on the Cloud.  Our clients include several global Biopharma companies and the FDA.  The FDA's NIMS solution is based on PointCross' DSIMS platform.  PointCross Life Sciences is a wholly owned subsidiary of PointCross, Inc.

Dr. Shree Nath, Vice President
PointCross Life Sciences, Inc. 
1291 E. Hillsdale Blvd., Suite 304
Foster City, CA 94404 
1-866-468-1900 or

SOURCE PointCross Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
2. Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meeting
3. Accel-KKR Makes Growth Equity Investment in Zinc Ahead, Leading Provider of Marketing Compliance Solutions for the Life Sciences Industry
4. Pfizer, GSK, and Siemens Form R&D Consortium With A*STARs Institute of Chemical & Engineering Sciences
5. NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI
6. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
7. Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
8. Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit
9. IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
10. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
11. BioDelivery Sciences Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting with FDA
Post Your Comments:
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... la première fois les différences entre les souches ... de celles des êtres humains . Ces ... comprendre et envisager la prise en charge efficace de ... ent diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):